Prejunctional adrenergic inhibition by aggregating platelets in canine blood vessels
- PMID: 4037113
- DOI: 10.1152/ajpheart.1985.249.3.H685
Prejunctional adrenergic inhibition by aggregating platelets in canine blood vessels
Abstract
Experiments were performed to determine the effect of aggregating platelets on adrenergic neurotransmission. Rings of canine saphenous veins and left circumflex coronary arteries were incubated with [3H]norepinephrine and suspended for superfusion. Aggregating platelets and exogenous 5-hydroxytryptamine decreased the overflow of [3H]norepinephrine evoked by electrical stimulation of the adrenergic nerve endings. The reduction of transmitter overflow caused by 5-hydroxytryptamine was prevented by the serotonergic antagonist methiothepin in a concentration that did not significantly affect the release of 5-hydroxytryptamine or thromboxane B2 from the aggregating platelets. Methiothepin decreased but did not abolish the inhibitory effect of aggregating platelets on neurotransmitter overflow. These experiments demonstrate that 5-hydroxytryptamine and other substances released from aggregating platelets can exert prejunctional inhibition of adrenergic neurotransmission in isolated blood vessels.
Similar articles
-
Adenine nucleotides and 5-hydroxytryptamine released by aggregating platelets inhibit adrenergic neurotransmission in canine coronary artery.J Clin Invest. 1986 Feb;77(2):369-75. doi: 10.1172/JCI112314. J Clin Invest. 1986. PMID: 3003158 Free PMC article.
-
Aggregating human platelets cause direct contraction and endothelium-dependent relaxation of isolated canine coronary arteries. Role of serotonin, thromboxane A2, and adenine nucleotides.J Clin Invest. 1986 Aug;78(2):539-44. doi: 10.1172/JCI112606. J Clin Invest. 1986. PMID: 3734103 Free PMC article.
-
Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine.J Clin Invest. 1985 Jan;75(1):286-92. doi: 10.1172/JCI111687. J Clin Invest. 1985. PMID: 3965509 Free PMC article.
-
Histamine and 5-hydroxytryptamine-inhibition of transmitter release mediated by H2- and 5-hydroxytryptamine receptors.Fed Proc. 1978 Feb;37(2):195-8. Fed Proc. 1978. PMID: 23966 Review.
-
Interaction between S2-serotonergic and alpha 1-adrenergic receptor activities at vascular sites.J Cardiovasc Pharmacol. 1988;11 Suppl 1:S10-5. J Cardiovasc Pharmacol. 1988. PMID: 2459506 Review.
Cited by
-
Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause.Biol Sex Differ. 2013 Mar 28;4(1):6. doi: 10.1186/2042-6410-4-6. Biol Sex Differ. 2013. PMID: 23537114 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources